title: Comment to the paper "The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brain stem glioma" by Burzynski et al.
authors.affiliation: Pediatric Neurosurgery, Division of Neurosurgery, Department of Surgery, Cheng Hsin General Hospital, Taipei, Taiwan, ttwong@vghtpe.gov.tw.
authors.forename: Tai-Tong
authors.initials: TT
authors.lastname: Wong
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D044482:Benzeneacetamides / Q000627:therapeutic use*; D020295:Brain Stem Neoplasms / Q000188:drug therapy*; D005260:Female; D005910:Glioma / Q000188:drug therapy*; D005973:Glutamine / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010648:Phenylacetates / Q000627:therapeutic use*; D010881:Piperidones / Q000627:therapeutic use*; D011149:Pons
chemical_list: D044482:Benzeneacetamides; D010648:Phenylacetates; D010881:Piperidones; D005973:Glutamine